CTL019

Profit finally in sight for gene therapy specialist Oxford Bio
Yahoo/Reuters
Wed, 08/23/17 - 10:07 pm
gene therapy
Oxford BioMedica
CTL019
Novartis
New CAR-T drug for leukemia, while effective, is ‘going to cost a fortune’
Stat
Wed, 08/23/17 - 11:41 am
CAR-T
Novartis
drug pricing
CTL019
leukemia
How Novartis' FDA Win In Cancer Also Could Be A Boon For Its Rivals
Investors Business Daily
Fri, 07/14/17 - 08:07 am
Novartis
CAR-T
CTL019
Kite Pharma
Bluebird Bio
Novartis wins unanimous support from FDA panel on groundbreaking CAR-T med
Fierce Pharma
Wed, 07/12/17 - 04:29 pm
Novartis
CAR-T
FDA
advisory panels
CTL019
D-day: Novartis arrives at a crossroad in the blockbuster race to win the first FDA OK for CAR-T
Endpoints
Wed, 07/12/17 - 11:00 am
Novartis
FDA
CAR-T
CTL019
Novartis turns to Oxford BioMedica for a major CAR-T supply deal
Endpoints
Thu, 07/6/17 - 02:35 pm
Novartis
Oxford BioMedica
CAR-T
CTL019
Novartis’s Next Challenge: Pricing Breakthrough Cancer Treatment
Bloomberg
Thu, 06/8/17 - 10:24 pm
Novartis
drug pricing
CTL019
cancer
CAR-T
Novartis' CAR-T stacks up to Kite in lymphoma
BioPharma Dive
Wed, 06/7/17 - 07:04 pm
Novartis
CAR-T
Kite Pharma
CTL019
axi-cel
lymphoma
July 12 FDA panel review looms as a watershed moment in Novartis’ campaign to win an historic new drug OK
Endpoints
Tue, 06/6/17 - 12:13 pm
Novartis
FDA
CAR-T
advisory panels
CTL019
pediatric B-cell acute lymphoblastic leukemia
Novartis Snags Coveted FDA 'Breakthrough' Label for CAR-T, Trial Results Still Under Wraps
TheStreet.com
Tue, 04/18/17 - 09:49 am
Novartis
Kite Pharma
FDA
CAR-T
breakthrough status
CTL019
Novartis Keeps 'JULIET' Study Results Close as Investors and Rival Kite Pharma Wait
TheStreet.com
Fri, 04/7/17 - 09:45 am
Novartis
Kite Pharma
CTL019
diffuse large B-cell lymphoma
Novartis Makes Its Case For Driving A CAR Into The Real World
Seeking Alpha
Mon, 12/5/16 - 10:43 pm
Novartis
CAR-T
Kite Pharma
CTL019
KTE-C19
In wake of a CAR-T restructuring, Novartis says it’s ready to hunt a pioneering OK for lead program
Endpoints
Sun, 12/4/16 - 12:24 pm
Novartis
CAR-T
CTL019
B-cell acute lymphoblastic leukemia
Novartis: Lymphoma study shows CART on track for 2017 U.S. submission
Yahoo/Reuters
Mon, 12/7/15 - 03:08 pm
Novartis
CAR-T
CTL019
non-Hodgkins lymphoma
Novartis: Lymphoma study shows CART on track for 2017 U.S. submission
Yahoo/Reuters
Sun, 12/6/15 - 11:06 am
Novartis
CAR-T
CTL019
non-Hodgkin's lymphoma
Novartis team tracks remissions of 4-plus years in a pioneering CAR-T study
Fierce Biotech
Thu, 09/3/15 - 08:40 am
Novartis
CAR-T
CTL019
CLL
chronic lymphocytic leukemia
What biopharma needs to know about CAR-T cancer therapies
BioPharma Dive
Sun, 04/26/15 - 09:21 am
CAR-T
Novartis
CTL019
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
Are Cancer Vaccines Worth an Investment?
Motley Fool
Thu, 07/10/14 - 10:28 am
vaccines
cancer
CTL019
Provenge
Dendreon
Novartis
Bristol-Myers Squibb
Novartis Needs Special Delivery for Potent Cell Therapy
Bloomberg
Wed, 12/18/13 - 08:16 am
Novartis
cancer cell therapy
CTL019

Pages